RecruitingPhase 3NCT03965988
Docosahexaenoic Acid on Breath Holding Spells in Children
Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial
Sponsor
Sherief Abd-Elsalam
Enrollment
60 participants
Start Date
May 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
DHA on Breath Holding Spells
Eligibility
Min Age: 1 MonthMax Age: 5 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called DHA and a drug called Placebo for people with breath holding attack. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Month to 5 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDHA
Docosahexaenoic acid
DRUGPlacebo
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03965988